For an intravitreal injection of ranibizumab (Lucentis, Genentech) for diabetic macular edema (DME), the indicated dosage is 0.3 mg, and the HCPCS code J2778 descriptor is injection, ranibizumab, 0.1 mg
Clinical trials have shown that patients using tirzepatide achieved greater reductions in blood sugar compared to those using other medications
You can even purchase these compounds online under certain nomenclature, chief among which is not for human consumption and only for research purposes
Zhang, Y., Gao, S., Liang, K., Wu, Z., Yan, X., & Liu, W